{"id":80170,"date":"2026-05-01T12:01:00","date_gmt":"2026-05-01T12:01:00","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/"},"modified":"2026-05-01T12:01:00","modified_gmt":"2026-05-01T12:01:00","slug":"invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/","title":{"rendered":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics"},"content":{"rendered":"<div>\n<p>JUNCTION CITY, Kan., May  01, 2026  (GLOBE NEWSWIRE) &#8212; InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for biologics manufacturing, announced its participation in the IPEC Excipient World Biologics Summit, which will take place May 4\u20136, 2026, in Nashville, TN. At the event, the company will highlight its recombinant human serum albumin (rHSA) portfolio, designed to support formulation stability, consistency, and performance in injectable biologics, vaccines, and advanced therapies.<\/p>\n<p>InVitria\u2019s rHSA has been used in commercially approved injectable medicines administered across hundreds of thousands of doses, including Merck\u2019s ERVEBO\u00ae Ebola Zaire vaccine. This regulatory precedent positions recombinant albumin as a reliable, animal-origin-free alternative to plasma-derived HSA for final drug product formulations.<\/p>\n<p>Formulation scientists have two excipient-grade options for injectable use:<\/p>\n<ul type=\"disc\">\n<li><strong>Exbumin\u00ae<\/strong>, a lyophilized recombinant human serum albumin powder, available in 10 g, 100 g, 1 kg, and bulk formats<\/li>\n<li style=\"margin-bottom:8pt;\"><strong>Optibumin\u00ae 25<\/strong>, a sterile 25% liquid recombinant human serum albumin, available in 100 mL closed-system-compatible bags and bottles for GMP manufacturing\n<\/li>\n<\/ul>\n<p>Scott Deeter, CEO of InVitria, will present <strong>\u201cFrom Novel Excipient to Gold Standard: The Recombinant Albumin Journey\u201d<\/strong> on <strong>Monday, May 4, 2026<\/strong>, on Monday, May 4, 2026, during the Biologics Summit.<\/p>\n<p><em>\u201cOur recombinant albumins provide the regulatory confidence and performance our customers demand,\u201d said Deeter. \u201cOptibumin 25 delivers the consistency and scalability required for modern biologics manufacturing.\u201d<\/em><\/p>\n<p>Jacob Weber, Ph.D., Vice President of Product Development, added, \u201cOur recombinant albumin consistently demonstrates &lt;0.5% aggregates by SEC-HPLC and ~99% Cys34 free thiol, supporting predictable performance and strong lot-to-lot reproducibility.\u201d<\/p>\n<p><strong>Key Benefits of InVitria\u2019s rHSA Portfolio:<\/strong><\/p>\n<ul type=\"disc\">\n<li>Animal- and blood-free, produced via the ExpressTec&#x2122; platform<\/li>\n<li>cGMP-compliant with low endotoxin and high consistency<\/li>\n<li>Demonstrated performance in stability, cryopreservation, and viral vector formulation<\/li>\n<li style=\"margin-bottom:8pt;\">Scalable supply with closed-system formats\n<\/li>\n<\/ul>\n<p>Attendees can visit InVitria at <strong>Booth #328<\/strong> or schedule a meeting at info@invitria.com.<\/p>\n<p><strong>About InVitria<\/strong><\/p>\n<p>InVitria develops and manufactures chemically defined, animal-origin-free recombinant proteins and cell culture supplements used in biologics production. Manufactured in the United States at an ISO 9001:2015-certified, cGMP-compliant facility, its portfolio includes Exbumin\u00ae, Optibumin\u00ae 25, Cellastim\u00ae S, Optiferrin\u00ae, Lacromin\u00ae, Lysobac\u00ae, OptiVERO\u00ae, and ITS Animal Free&#x2122; supplements. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HxK42APJDerrXvMtX39f0IvKk-zX5qIdWZ2NTRSKYWhS_S6M63I4YDk1s4qmirX4Vt_Ly11b7q8_E-5aqLfnUYgu8_FQmsJzaOXnZweNmho=\" rel=\"nofollow\" target=\"_blank\" title=\"\">http:\/\/www.invitria.com<\/a><\/p>\n<p><strong>For more information, visit\u00a0<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s_-yOGh4vGcQvi-KSFAbicRGFkQk9NVv2LUuSC0r8rHcqCedQCm_dw3qxREz6EdUG3KXqqZKOOeIcIFqRXL_1VwI-AlbH9jDwwih7PvOTTA=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>www.InVitria.com<\/strong><\/a>\u00a0<strong>or contact info@invitria.com.<\/strong><\/p>\n<pre>CONTACT: For media inquiries, please contact:\r\n\r\nAlexia Armstrong\r\nDirector of Marketing\r\nInVitria, Inc.\r\nAarmstrong@invitria.com\r\nhttp:\/\/www.invitria.com<\/pre>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTBmZmM2ODYtZGZlYi00ZTE2LTk5ODQtNDVlNjI4ZmM5Y2FjLTEzMTA1NDEtMjAyNi0wNS0wMS1lbg==\/tiny\/InVitria.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JUNCTION CITY, Kan., May 01, 2026 (GLOBE NEWSWIRE) &#8212; InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for biologics manufacturing, announced its participation in the IPEC Excipient World Biologics Summit, which will take place May 4\u20136, 2026, in Nashville, TN. At the event, the company will highlight its recombinant human serum albumin (rHSA) [&#8230;]\n","protected":false},"author":1,"featured_media":80171,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-80170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics\" \/>\n<meta property=\"og:description\" content=\"JUNCTION CITY, Kan., May 01, 2026 (GLOBE NEWSWIRE) &#8212; InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins fo\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-01T12:01:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1075\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics\",\"datePublished\":\"2026-05-01T12:01:00+00:00\",\"dateModified\":\"2026-05-01T12:01:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\"},\"wordCount\":374,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\",\"name\":\"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-05-01T12:01:00+00:00\",\"dateModified\":\"2026-05-01T12:01:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/","og_locale":"en_US","og_type":"article","og_title":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics","og_description":"JUNCTION CITY, Kan., May 01, 2026 (GLOBE NEWSWIRE) &#8212; InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins fo","og_url":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-05-01T12:01:00+00:00","og_image":[{"width":1075,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics","datePublished":"2026-05-01T12:01:00+00:00","dateModified":"2026-05-01T12:01:00+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/"},"wordCount":374,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/","url":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/","name":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-05-01T12:01:00+00:00","dateModified":"2026-05-01T12:01:00+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market-approved-biologics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"InVitria Showcases Exbumin\u00ae and Optibumin\u00ae 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=80170"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80170\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/80171"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=80170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=80170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=80170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}